Literature DB >> 19925970

Screening and preventive therapy for tuberculosis.

Ben J Marais1, Helen Ayles, Stephen M Graham, Peter Godfrey-Faussett.   

Abstract

The tuberculosis (TB) epidemic is well controlled in most developed countries and the focus in these areas has shifted to TB eradication. Transmission within nonendemic areas is limited and most cases of TB result from reactivation of distant (latent) infection. With adequate resources, wide-scale use of preventive therapy can assist to eliminate the pool of latent infection that is required for TB eradication. In contrast, TB control remains poor in many developing countries, especially those worst affected by poverty and the human immunodeficiency virus (HIV) epidemic. In this review the authors critically assess the approach to TB preventive therapy in children and adults, focus on the underlying treatment rationale, discuss available data and identify issues of concern.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925970     DOI: 10.1016/j.ccm.2009.08.012

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  19 in total

Review 1.  Childhood tuberculosis: epidemiology and natural history of disease.

Authors:  Ben J Marais
Journal:  Indian J Pediatr       Date:  2011-01-07       Impact factor: 1.967

2.  Impact of tuberculosis on maternal and child health.

Authors:  Ben J Marais
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 4.  Tuberculosis in children.

Authors:  Ben J Marais; H Simon Schaaf
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-18       Impact factor: 6.915

Review 5.  Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis.

Authors:  Helen E Jenkins; Courtney M Yuen; Carly A Rodriguez; Ruvandhi R Nathavitharana; Megan M McLaughlin; Peter Donald; Ben J Marais; Mercedes C Becerra
Journal:  Lancet Infect Dis       Date:  2016-12-08       Impact factor: 25.071

6.  Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia.

Authors:  Merrin E Rutherford; Rovina Ruslami; Melissa Anselmo; Bachti Alisjahbana; Neti Yulianti; Hedy Sampurno; Reinout van Crevel; Philip C Hill
Journal:  Bull World Health Organ       Date:  2013-09-10       Impact factor: 9.408

7.  Isoniazid preventive therapy in child household contacts of adults with active TB in Bamako, Mali.

Authors:  M Tolofoudie; A Somboro; B Diarra; Y S Sarro; H B Drame; A C G Togo; M Sanogo; A Dembele; T Togun; E Nkereuwem; B Baya; B Konate; U Egere; M Traore; M Maiga; K Saliba-Shaw; B Kampmann; S Diallo; S Doumbia; M Sylla
Journal:  Public Health Action       Date:  2021-12-21

8.  Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression.

Authors:  Davinder P S Dosanjh; Mustafa Bakir; Kerry A Millington; Ahmet Soysal; Yasemin Aslan; Serpil Efee; Jonathan J Deeks; Ajit Lalvani
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

9.  Contact investigation of children exposed to tuberculosis in South East Asia: a systematic review.

Authors:  Rina Triasih; Merrin Rutherford; Trisasi Lestari; Adi Utarini; Colin F Robertson; Stephen M Graham
Journal:  J Trop Med       Date:  2011-11-15

10.  Isoniazid preventive treatment in children in two districts of South India: does practice follow policy?

Authors:  H R Shivaramakrishna; A Frederick; A Shazia; L Murali; S Satyanarayana; S A Nair; A M Kumar; P K Moonan
Journal:  Int J Tuberc Lung Dis       Date:  2014-08       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.